Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) jumped 3.8% in the afternoon session after Mizuho analyst ...

Benco Dental will offer Dentsply Sirona’s full portfolio of dental technology solutions, in addition to the consumables portfolio. Expanding the ...

Explore Dentsply Sirona (XRAY): global dental tech leader, key segments, and why its investment-grade bonds yielding 8.5% ...

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is one of the stocks Jim Cramer offered insights on. Toward the end of the lightning round ...

Company’s Board of Directors forms Growth and Value Creation Committee to guide the Company’s Return-to-Growth Action PlanCHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc.

DENTSPLY SIRONA recently renewed its U.S. dental technology distribution agreement with Patterson Dental and expanded its ...

Management reaffirmed the full-year 2025 guidance for organic sales to decline by 2%-4% and adjusted EPS to remain in the range of $1.80 to $2. Reported sales guidance was revised upward to $3.6 ...

DENTSPLY SIRONA’s latest update trims its fair value estimate slightly from US$12.96 to US$12.83 per share, while also adjusting key model inputs like the discount rate and revenue growth assumptions.

Sirona is not beating around the bush: the company has had a difficult time selling its diabetes med and is now “less confident” it will score a licensing deal. The candid about-face came in a ...

Just months after exiting from stealth last August with $62.5 million in Series A and B financing, San Francisco-based Sirona Medical, a software company, announced its first acquisition: Nines’ ...